Plasmapp Co Ltd is a Korea-based company mainly engaged in the provision of medical solutions. The Company is engaged in the provision of low temperature plasma sterilization solutions, implant regeneration and activation solutions. The Company is also engaged in the manufacture and sale of medical devices. The Company's products include sterilizers, sterile consumables, regenerative activators, consumables, accessories and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
28/06/26	₩3,755.00	+2.74%	12,706
26/06/26	₩3,655.00	+4.43%	9,695
25/06/26	₩3,500.00	-8.97%	16,994
24/06/26	₩3,845.00	+6.36%	14,521
23/06/26	₩3,615.00	-2.43%	31,985

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 29/06/2026			5-day change	1st Jan Change
3,755.00 ^KRW	+2.74%		-4.57%	-35.26%

06-04	South Korean Shares Close Nearly 2% Lower on Overnight Wall Street Losses, Fresh Middle East Tensions	MT
06-04	Plasmapp Clinches KRW3.5 Billion Supply Contract	MT

Market Cap	14.41B 9.34M 8.18M 7.55M 7.05M 13.27M 883M 13.57M 90.85M 35.07M 436M 35.07M 34.3M 1.51B	P/E 2024	-1.45x	P/E 2025	-3.03x
Enterprise Value	19.73B 12.79M 11.2M 10.34M 9.65M 18.17M 1.21B 18.58M 124M 48.02M 596M 48.02M 46.97M 2.07B	EV / Sales 2024	4.06x	EV / Sales 2025	3.25x
Free-Float	45.8%	Yield 2024 *	-	Yield 2025	-

06-04	South Korean Shares Close Nearly 2% Lower on Overnight Wall Street Losses, Fresh Middle East Tensions	MT
06-04	Plasmapp Clinches KRW3.5 Billion Supply Contract	MT
03-31	Plasmapp wins 2.5 billion won order	RE
31/03/25	Plasmapp To Conduct Capital Increase Of 7.4 Billion Won	RE
30/03/25	Plasmapp Co., Ltd. announced that it expects to receive KRW 7.3599448 billion in funding from DREAMTECH Co., Ltd., Namuga Co., Ltd. and other investors	CI
28/07/24	Plasmapp Co., Ltd. announced that it has received KRW 15.36492551 billion in funding from DREAMTECH Co., Ltd., Namuga Co., Ltd.	CI
17/07/24	Plasmapp Co., Ltd. announced that it expects to receive KRW 15.36492551 billion in funding from DREAMTECH Co., Ltd., Namuga Co., Ltd.	CI
20/04/24	Plasmapp Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding	CI
20/11/23	AdaptivEndo and Plasmapp Collaborate to Develop Sterilization Techniques for Flexible Endoscopy	CI
27/06/23	Plasmapp Co., Ltd. announced that it has received KRW 5.46494676 billion in funding from C & C Co., Ltd.	CI
21/06/23	Plasmapp to Raise 5.5 Billion Won via Shares Issuance	MT
19/06/23	Plasmapp Co., Ltd. announced that it expects to receive KRW 5.46494676 billion in funding from C & C Co., Ltd. and other investors	CI
23/03/23	Plasmapp Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

1 day	+2.74%
1 week	-4.57%
Current month	-28.20%
1 month	-30.20%
3 months	-50.00%
6 months	-40.49%
Current year	-35.26%

Plasmapp Co., Ltd. Share Price

Stocks

A405000

KR7405000001

Medical Equipment, Supplies & Distribution

Valuation: Plasmapp Co., Ltd.

Chart: Plasmapp Co., Ltd.

Latest news : Plasmapp Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Plasmapp Co., Ltd.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	3,155	4,000
1 month	3,155	6,560
Current year	3,155	9,200
1 year	3,155	9,400
3 years	3,155	63,900
5 years	3,155	91,500
10 years	3,155	91,500

Manager	Title	Age	Since
Hyung-Min Kim CEO	Chief Executive Officer	56	12/09/2024
Jeong-Hun Lee PRN	Corporate Officer/Principal	48	27/03/2024
Yu-Bong Lim CEO	Chief Executive Officer	45	31/12/2014

Director	Title	Age	Since
Yu-Bong Lim BRD	Director/Board Member	45	12/03/2024
Hyung-Min Kim BRD	Director/Board Member	56	12/09/2024
Yong-Cheol Kim BRD	Director/Board Member	52	12/09/2024

Date	Insider	Type	Quantity	% Market Cap.
28/01/24	Hyeon-Dong Yeo	Sell	3,000	0.0155%
28/01/24	Gyu-Ho Hwang	Sell	1,428	0.0074%
03/01/24	Hyeon-Dong Yeo	Others	3,000	0.0155%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PLASMAPP CO., LTD.	+2.74%	-4.57%	-57.57%	-94.05%	9.14M
ABBOTT LABORATORIES	-1.50%	+5.56%	-31.84%	-13.89%	164B
MEDTRONIC PLC	-0.06%	+2.09%	-7.16%	-6.73%	104B
CENCORA, INC.	-1.57%	+3.82%	-6.07%	+47.83%	55.67B
HOYA CORPORATION	+0.90%	-5.29%	+52.20%	+53.60%	52.92B
BECTON, DICKINSON AND COMPANY	-0.47%	+10.29%	-9.90%	-40.43%	42.96B
MEDLINE INC.	+1.90%	+14.12%	-	-	32.87B
DEXCOM, INC.	-0.23%	+1.32%	-19.83%	-45.30%	27.07B
WEST PHARMACEUTICAL SERVICES, INC.	+1.09%	+7.57%	+62.10%	-6.01%	24.79B
STERIS PLC	-1.13%	+6.41%	-11.23%	-3.51%	21.02B
Average	+0.24%	+3.82%	-3.26%	-12.05%	52.49B
Weighted average by Cap.	-0.29%	+3.98%	-6.50%	-1.34%

	2024	2025
Net sales	10.14B 6.57M 5.75M 5.31M 4.96M 9.34M 621M 9.55M 63.93M 24.68M 307M 24.68M 24.14M 1.06B	8.48B 5.5M 4.81M 4.44M 4.15M 7.81M 520M 7.99M 53.49M 20.65M 256M 20.65M 20.2M 890M
Net income	-20.78B -13.47M -11.8M -10.89M -10.17M -19.14M -1.27B -19.58M -131M -50.59M -628M -50.6M -49.48M -2.18B	-6.59B -4.27M -3.74M -3.45M -3.22M -6.07M -404M -6.21M -41.53M -16.03M -199M -16.03M -15.68M -691M
Net Debt	6.69B 4.33M 3.79M 3.5M 3.27M 6.16M 410M 6.3M 42.15M 16.27M 202M 16.27M 15.92M 702M	5.32B 3.45M 3.02M 2.79M 2.6M 4.9M 326M 5.01M 33.55M 12.95M 161M 12.95M 12.67M 558M